Ke Xiao

Shantou University - Medical College

SCHOLARLY PAPERS

1

DOWNLOADS

33

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of LY01610 (an Irinotecan Hydrochloride Liposome Injection) as a Second-Line Treatment for Relapsed Small Cell Lung Cancer (SCLC)

Number of pages: 49 Posted: 19 Mar 2024
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Medical Oncology, Government of the People's Republic of China - Second People's Hospital of Yibin, Bengbu Medical College - Department of Medical Oncology, Xuzhou Central Hospital - Department of Medical Oncology, Bengbu Medical College - Department of Medical Oncology, Guangdong Pharmaceutical University - Department of Medical Oncology, Shantou University - Medical College, Guangzhou Medical University, Xingtai People's Hospital, Chongqing Medical University, University of Science and Technology of China (USTC) - Department of Thoracic Cancer Chemotherapy, University of Science and Technology of China (USTC), Chongqing University, Chongqing University, Chongqing University, Luye Life Sciences Group, Nanjing Luye Pharmaceutical Co Ltd and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs
Downloads 33 (998,534)

Abstract:

Loading...

irinotecan liposome, LY01610, relapsed small cell lung cancer